Abstract:Solitary plasmacytoma (SP) is a rare disease. It is characterized by a localized proliferation of neoplastic monoclonal plasma cells either in the bone (solitary bone plasmacytoma, SBP) or in soft tissue (solitary extramedullary plasmacytoma, SEP). The prognosis of SBP is poorer than SEP due to its higher rate of progression to multiple myeloma (MM). There is no uniform consensus regarding the disease prognosis and treatment due to a very limited understanding of the disease pathophysiology. Sphingosine 1‐phosphate (S1P) has been identified as an important signaling molecule promoting various cancer cell growth. S1P is synthesized by two protein kinases, sphingosine kinase 1 and 2 (SphK1 and SphK2, in cytosol and nuclear respectively). Extensive studies have been done with SphK1 in various cancer cells. However, the contribution of SphK2‐mediated signaling in cancer cell growth remains largely unknown, especially in SP. The current study is aimed to examine the expression of SphK2 in SP cells and further define the role of SphK2 in cell growth. Methods Studies were conducted in the human SP cell lines, AMO‐1, NCI‐H929 and RPMI8226. The expression of SphK1 and Sphk2 was determined by real‐time RT‐PCR and Western blot analysis and confirmed by DNA sequencing. The SphK2 inhibitor, K145, and gene‐specific shRNA were used to inhibit SphK2 activation and expression. Cell proliferation was determined using a CCK‐8 kit. Cell apoptosis was analyzed by Annexin V‐FITC/PI staining followed by flow cytometry. Results The expression level of SphK2 in all tested SP cell lines was significantly higher than SphK1. S1P significantly induced cell proliferation, migration and invasion of SP cells, which was inhibited by K145 as well as gene specific shRNA targeting SphK2. AMO‐1 has the highest SphK2 expression level among all three tested cell lines both at the mRNA and protein levels. The SphK2 expression level is correlated to invasiveness of SP cell growth and inversely related to the sensitivity to K145‐induced apoptosis. Discussion/Conclusion SphK1 and SphK2 are all expressed in human SP cancer cells. However, SphK2 expression level is much higher than SphK1. In this study, by using a chemical inhibitor and gene‐specific shRNA, we were able to show that SphK2 plays a critical role in SP cell growth. Due to the limited efficacy of conventional chemotherapy, there is an urgent need to develop new therapeutics. The results in this study suggest that targeting SphK2 may represent a novel therapy for SP. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Prognostic significance of sphingosine kinase 2 expression in non-small cell lung cancer

Increased Sphingosine Kinase 1 Expression is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis

Prognostic Roles of the Expression of Sphingosine-1-phosphate Metabolism Enzymes in Non-Small Cell Lung Cancer

The prognostic significance of SHP2 and its binding protein Hook1 in non-small cell lung cancer.

Expression of SPNS2 in colorectal cancer tissues and its clinical significance

Sphingosine Kinase 1 is Associated with Gastric Cancer Progression and Poor Survival of Patients

Expression of sphingosine kinase 1 in breast cancer and its clinical significance

Skp2 Expression Has Different Clinicopathological and Prognostic Implications in Lung Adenocarcinoma and Squamous Cell Carcinoma

Overexpression of Sphk2 is associated with gefitinib resistance in non-small cell lung cancer

[Relationship Between Sphingosine Kinase 1 Expression and Tumor Invasion, Metastasis and Prognosis in Gastric Cancer].

Overexpression of S100A2 Protein As a Prognostic Marker for Patients with Stage I Non Small Cell Lung Cancer

Proline-rich Tyrosine Kinase 2 and Its Phosphorylated Form Py881 Are Novel Prognostic Markers for Non-Small-cell Lung Cancer Progression and Patients’ Overall Survival

The Clinicopathological and Prognostic Implications of Tyrosine Phosphatase SHP2 and Ankyrin Hook1 Gene Expression in Non- Small Cell Lung Cancer Patients Treated with Gemcitabine Plus Platinum As First-Line Chemotherapy

Kinesin family member 2A high expression correlates with advanced tumor stages and worse prognosis in non-small cell lung cancer patients

SLP-2 overexpression is associated with tumour distant metastasis and poor prognosis in pulmonary squamous cell carcinoma.

Expression and Clinicopathological Significance of S-Phase Kinase Associated Protein in Benign and Malignant Lesions of Human Breast Tissues

The prognostic value of Skp 2 expression level in cancer : a meta-analysis

Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy

Overexpression of Karyopherin Α2 in Small Cell Carcinoma of the Cervix Correlates with Poor Prognosis.

Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival

K145, a sphingosine kinase 2 inhibitor, inhibits solitary plasmacytoma cell growth